Brandi L. Roberts
2023 - Longboard Pharmaceuticals
In 2023, Brandi L. Roberts earned a total compensation of $1M as Executive Vice President and Chief Financial Officer at Longboard Pharmaceuticals, a 19% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $211,411 |
---|---|
Option Awards | $362,547 |
Salary | $436,800 |
Other | $14,442 |
Total | $1,025,200 |
Roberts received $436.8K in salary, accounting for 43% of the total pay in 2023.
Roberts also received $211.4K in non-equity incentive plan, $362.5K in option awards and $14.4K in other compensation.
Rankings
In 2023, Brandi L. Roberts' compensation ranked 1,169th out of 2,918 executives tracked by ExecPay. In other words, Roberts earned more than 59.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,169 | 60th |
Manufacturing | 702 | 56th |
Chemicals And Allied Products | 471 | 48th |
Drugs | 459 | 47th |
Pharmaceutical Preparations | 315 | 49th |
Roberts' colleagues
We found two more compensation records of executives who worked with Brandi L. Roberts at Longboard Pharmaceuticals in 2023.
News
Longboard Pharmaceuticals CEO Kevin Lind's 2023 pay jumps 36% to $2.1M
April 12, 2024
Longboard Pharmaceuticals CEO Kevin Lind's 2022 pay jumps 72% to $1.5M
April 11, 2023
Longboard Pharmaceuticals CFO Brandi Roberts receives $1.3M in 2021
April 13, 2022
BioTime CFO Brandi Roberts receives $948K in 2019
August 7, 2020